Vanessa Brosan
Family · Wendell, NCNPI 1598117079
Payments from drug & device makers
Across 392 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Bayer$991
- Novo Nordisk$923
- GSK$808
- Amgen$754
- AbbVie$602
- plus $2K from 20 others
What the payments were for
- Food & beverage$7,36599%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $1,478 |
| Bayer | 41 | $991 |
| Novo Nordisk | 58 | $923 |
| GSK | 51 | $808 |
| Amgen | 52 | $754 |
| AbbVie | 36 | $602 |
| Novartis | 17 | $270 |
| Lilly USA, LLC | 14 | $253 |
| Merck | 14 | $224 |
| Mylan Specialty L.p. | 12 | $205 |
| Boehringer Ingelheim | 8 | $130 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $109 |
| Otsuka America Pharmaceutical, Inc. | 6 | $97 |
| Pfizer | 6 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $86 |
| Viatris Specialty LLC | 4 | $68 |
| Abbott | 3 | $62 |
| Sanofi-aventis U.S. LLC | 4 | $56 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Exact Sciences | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $29 |
| Seqirus USA Inc | 1 | $22 |
| Lundbeck LLC | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,410 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 49 | $65,784 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $64,773 |
| JardianceEmpagliflozin | 43 | $42,118 |
| KerendiaFinerenone | 31 | $38,414 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $31,080 |
| EliquisApixaban | 22 | $27,503 |
| FarxigaDapagliflozin Propanediol | 34 | $26,590 |
| MounjaroTirzepatide | 18 | $24,614 |
| VraylarCariprazine Hcl | 14 | $19,197 |
| XareltoRivaroxaban | 12 | $14,898 |
| Repatha SureclickEvolocumab | 14 | $12,062 |
| Atorvastatin Calcium | 217 | $2,575 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,174 |
| Gabapentin | 99 | $1,802 |
| Pravastatin Sodium | 83 | $1,543 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $923 | $65,78449 claims |
| GSKTrelegy Ellipta | $808 | $64,77367 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $1,478 | $57,67075 claims |
| Boehringer IngelheimJardiance | $130 | $42,11843 claims |
| BayerKerendia | $991 | $38,41431 claims |
| PfizerEliquis | $97 | $27,50322 claims |
| Lilly USA, LLCMounjaro | $253 | $24,61418 claims |
| AbbVieVraylar | $602 | $19,19714 claims |
| Johnson & JohnsonXarelto | $29 | $14,89812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.
Other family in Wendell
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.